Last10K.com

Acasti Pharma Inc. (ACST) SEC Filing 40-F Annual report for the fiscal year ending Thursday, February 28, 2013

SEC Filings

Acasti Pharma Inc.

CIK: 1444192 Ticker: ACST

View differences made from one year to another to evaluate Acasti Pharma Inc.'s financial trajectory

Compare SEC Filings Year-over-Year (YoY) and Quarter-over-Quarter (QoQ)
Sample 10-K Year-over-Year (YoY) Comparison

Compare this 40-F Annual Report to its predecessor by reading our highlights to see what text and tables were  removed  ,   added    and   changed   by Acasti Pharma Inc..

Continue

Assess how Acasti Pharma Inc.'s management team is paid from their Annual Proxy

Definitive Proxy Statement (Form DEF 14A)
Screenshot example of actual Proxy Statement

Acasti Pharma Inc.'s Definitive Proxy Statement (Form DEF 14A) filed after their 2013 10-K Annual Report includes:

  • Voting Procedures
  • Board Members
  • Executive Team
  • Salaries, Bonuses, Perks
  • Peers / Competitors

Continue

SEC Filing Tools
Ticker: ACST
CIK: 1444192
Form Type: 40-F Annual Report
Accession Number: 0001171843-13-002319
Submitted to the SEC: Wed May 29 2013 6:25:32 PM EST
Accepted by the SEC: Thu May 30 2013
Period: Thursday, February 28, 2013
Industry: Pharmaceutical Preparations

External Resources:
Stock Quote
Social Media

Bookmark the Permalink:
https://last10k.com/sec-filings/acst/0001171843-13-002319.htm